Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
IMUX similar filings
- 13 Nov 20 Entry into a Material Definitive Agreement
- 5 Nov 20 Immunic, Inc. Reports Third Quarter 2020 Financial Results and Provides Corporate Update
- 20 Oct 20 EIB Provides Immunic With up to €24.5 Million to Support Ongoing Development of a Potential COVID-19 Therapy
- 11 Sep 20 Regulation FD Disclosure
- 10 Aug 20 Entry into a Material Definitive Agreement
- 3 Aug 20 Immunic, Inc. Reports Positive Top-line Data from Phase 2 EMPhASIS Trial of IMU-838 in Patients with Relapsing-Remitting Multiple Sclerosis
- 27 Jul 20 Regulation FD Disclosure
Filing view
External links